Skip to content

Released Feb 18, 2025, after the close

10-K filed Feb 19, 2025, 50 days after period end · 0001653477-25-000015

Q4 2024 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$135.60Mderivedno prior Q4 2023 on file−59.4% vs Q3 2024
Net Income$16.60MderivedN/M vs Q4 2023N/M vs Q3 2024
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$110,300,000+238.3%
Operating Incomederived$137,500,000+55.9%
Operating Cash Flowderived$64,500,000+39.6%
Free Cash Flowderived$39,600,000+132.9%
Margins · derived
Gross margin81.3%
Operating margin101.4%
Net margin12.2%

What the release said

The release

Same quarter

MetricQ4 2024derived from reported figuresQ4 2023derived from reported figuresQ4 2022derived from reported figuresQ4 2021derived from reported figures
Revenue$135.60M—$383.60M$336.00M
Net Income$16.60M-$116.80M$15.60M$29.30M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR